Dale_Molecular Genetics of Bacteria 4th ed
.pdf340 |
INDEX |
Gene cloning (continued ) |
gene mapping, 174, 273–9 |
product formation, 234, 235–6 |
gene replacement, 262–4, 292 |
shuttle vectors, 239 |
genome sequencing, 282–5 |
transformation, 225, 239–41 |
lysogeny, 250–1 |
Gene copy number, 69 |
metabolic pathways, 245, 246 |
Gene expression, 21 |
microarrays, 286–7, 295–6 |
information flow, 67–69 |
microbial physiology, 247–9 |
operons, 34–35 |
motility and chemotaxis, 252–3 |
post-translational events, 32–4, 69 |
physical and genetic maps, 289–92 |
prokaryotes and eukaryotes, 35 |
reporter genes, 249–50 |
protein secretion, 33–4, 258 |
sequencing, 279–281 |
transcription, 22–6, 70–9, 87–92 |
site-directed mutagenesis, 292 |
translation, 26–32, 99–102 |
sporulation, 253–4 |
see also Regulation of gene |
transposon mutagenesis, 290–1 |
expression |
virulence, 257–62 |
Gene homology, 285 |
Genetic code, 26 |
Gene libraries |
Genetic modification, 215 |
cDNA libraries, 233–4 |
Genetic nomenclature, 46 |
construction, 229–31, 233–4 |
Genome plasticity, 186, 188, 189 |
gene mapping, 277 |
Genome sequencing, 135, 282–5 |
genomic libraries, 229–33, 277 |
bioinformatics, 288–9 |
ordered libraries, 277, 285 |
clone-by-clone strategy, 285 |
screening, 231–3 |
comparative genomics, 285–8 |
Gene mapping |
finishing, 284 |
conjugation, 273–5 |
protein prediction, 288–9 |
molecular techniques, 277–9 |
shotgun strategy, 284 |
transduction, 276–7 |
Genotype, 37, 45 |
transformation, 276–7 |
Glutamate, production, 220 |
Gene probes |
Green fluorescent protein, 250 |
bacterial detection, 267 |
Griffith, Fred, 166 |
gene mapping, 277 |
Haemophilus influenzae |
identification of mutants, 64–6, 237 |
transformation, 166–7 |
PCR, 231 |
vaccine, 241 |
screening libraries, 231 |
|
Gene replacement, 242, 262–4, 292 |
Hepatitis B virus, vaccine, 242 |
Gene transfer, 44, 270 |
Hybridization, 10, 64–6 |
conjugation, 167–78 |
Northern blots, 293 |
transduction, 178–80 |
Southern blots, 64–6 |
transformation, 166–7 |
stringency, 10, 231 |
Genes, overlapping, 107 |
See also Gene probes |
Genetic analysis |
|
cell communication, 255–7 |
In Vivo Expression Technology (IVET), |
cell division, 251 |
259 |
complementation, 246 |
Insertion sequences, 44, 189–92 |
cross-feeding, 246 |
activation of adjacent genes, 203–4 |
differentiation, 253–7 |
composite transposons, 194–6 |
gene expression, 234, 249–50, 292–9 |
copy number, 190–2 |
gene function, 289, 292 |
deletions, 156, 186, 191 |
342 |
INDEX |
Mutagenesis (continued ) |
Northern blotting, 293 |
site-directed, 237, 292 |
|
tautomerism, 50 |
Operators, 72, 79–80, 122–3 |
transposons, 290–1 |
constitutive mutants, 82–3 |
ultraviolet irradiation, 21, 54–7, 216 |
dyad symmetry, 80 |
Mutants |
Operons |
antibiotic resistant, 45, 58, 288 |
divergent transcription, 73 |
auxotrophs, 45, 58–59, 61 |
gene expression, 34, 72, 77, 88 |
bacteriophage-resistant, 38–40 |
operators, 72, 79 |
conditional, 42–3, 49, 128 |
structure, 34, 72 |
isolation, 58–62, 216–8 |
Origin of Species, 37 |
lactose fermentation, 62 |
OxyR, 213 |
molecular characterization, 62–6 |
|
nomenclature, 45–6 |
P1 bacteriophage |
penicillin enrichment, 61 |
prophage, 117, 137 |
polar, 42, 99, 263 |
transduction, 277 |
regulatory, 81–3, 217–9 |
Pathogenicity islands, 135, 258 |
temperature-sensitive, 43 |
pC194 plasmid, 151 |
Mutation |
Penicillin enrichment, 61 |
base substitutions, 41–2, 288 |
Penicillin, production, 220 |
chain terminating, 42, 43, 47–9, 128 |
Phage display, 132 |
deletions, 44 |
Phage therapy, 131–2 |
fluctuation test, 38–40 |
Phage typing, 131 |
frameshift, 42, 47, 54 |
Phase variation, 102, 205–13 |
insertional inactivation, 44, 189 |
DNA methylation, 213 |
inversion, 44, 207–8 |
gene conversion, 209–10 |
point mutations, 41–2 |
inversions, 207, 208 |
random or directed, 38, 60 |
slipped-strand mispairing, 211–2 |
reversion, 47 |
Phenotype, 37, 45 |
spontaneous, 14, 50–1 |
variability, 161 |
suppression, 43, 47–9, 128 |
f29 bacteriophage, 153 |
transposition, 44, 197 |
fX174 bacteriophage, 105–9 |
Mycobacterium leprae, 267, 286 |
assembly, 108 |
Mycobacterium tuberculosis |
overlapping genes, 106–7 |
antibiotic resistance, 288 |
replication, 107–8, 149–51 |
detection, 131, 267 |
structure, 106 |
genome, 286 |
Plasmids, 14, 44 |
strain typing, 268 |
antibiotic resistance, 137–8, 146, 163, |
Myxococcus xanthus, 98, 256–7 |
191, 192–3 |
|
biodegradation and bioremediation, |
N15 bacteriophage, 152 |
140–1 |
Neisseria gonorrhoeae |
classification, 147, 163–4 |
antigenic variation, 166, 208–11 |
cloning vectors, 223–4 |
transformation, 166 |
colicinogenic, 138 |
Neisseria meningitidis |
conjugative, 142, 167–8, 170–6 |
phase variation, 212 |
copy number, 142, 147–8, 157–8 |
transformation, 167 |
curing, 161 |
Nitrous acid, mutagenesis, 53 |
detection, 161–2 |
INDEX |
345 |
|
H antigens, 208 |
Streptococcus pyogenes, 133 |
|
identification, 139–40 |
Streptomyces |
|
phase variation, 208 |
antibiotic production, 221 |
|
virulence, 259 |
conjugation, 174–6 |
|
|
linear DNA, 151–4 |
|
Scaffolding, 106 |
plasmids, 153 |
|
Scarlet fever, 133 |
sporulation, 254 |
|
Sequence polymorphisms, 288 |
Streptomyces coelicolor, genome, 285 |
|
Shine-Dalgarno sequence, 27, 99 |
Stress responses, 32, 55–7, 74, 94–5 |
|
s-factors, 22, 74 |
Stringent response, 94, 101 |
|
alternative s-factors, 74–5, 94, 95, 112–3, |
Supercoiling, 6–10 |
|
254 |
gene expression, 72, 94 |
|
anti-s-factors, 77, 254 |
linking number, 7 |
|
Signal transduction, 92 |
topoisomerase, 7–10, 13 |
|
Signature tagged mutagenesis (STM), |
twist, 7 |
|
260–2 |
writhe, 7 |
|
Slipped-strand mispairing, 211–2, 268 |
Suppression, 43, 47–49, 128 |
|
SOS response, 57, 94 |
|
|
Southern blotting, 66 |
T4 bacteriophage, 105, 110–3 |
|
identification of mutants, 64 |
assembly, 110–1 |
|
strain typing, 268 |
circular permutation, 111 |
|
SPO1 bacteriophage, 112–3 |
early and late genes, 111–2 |
|
Sporulation, 75–7, 166, 253–4, 256–7 |
replication, 110 |
|
Staphylococcus aureus, phage typing, 131 |
rII mutants, 128 |
|
Starvation, 95 |
structure, 110 |
|
stringent response, 101 |
terminal redundancy, 110 |
|
Strain development |
Tandem repeats, 268 |
|
gene cloning, 221–2 |
Tautomerism, 50 |
|
mutation, 215–6 |
Taxonomy |
|
novel products, 235–8 |
DNA base composition, 264–5 |
|
primary metabolites, 216–20 |
phylogenetic trees, 265 |
|
protein engineering, 238 |
ribosomal RNA, 265 |
|
random screening, 216–8, 221 |
Tn10, 146, 194, 200 |
|
rational screening, 218 |
Tn21, 196 |
|
secondary metabolites, 216, 220–1 |
Tn3, 194, 197, 202–3 |
|
Strain typing |
Tn4, 195 |
|
microarrays, 286–7 |
Tn5, 195, 290 |
|
phage typing, 131 |
Tn7, 197 |
|
pulsed field gel electrophoresis (PFGE), |
Tn9, 195 |
|
279 |
Tn916, 176–8 |
|
restriction fragment length |
Transcription |
|
polymorphism (RFLP), 268–9 |
analysis, 293–6 |
|
variable number tandem repeats |
initiation, 22 |
|
(VNTR), 268 |
mechanism, 22–4 |
|
Streptococcus mitis, 187–8 |
termination, 24–6, 77–9, 87–9 |
|
Streptococcus pneumoniae |
Transcriptome, 296 |
|
penicillin resistance, 167, 187–8 |
Transduction, 165, 178–80 |
|
transformation, 166–7 |
co-transduction, 277 |
|